BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6132577)

  • 1. Interactions of neurotensin with brain dopamine systems.
    Nemeroff CB; Hernandez DE; Luttinger D; Kalivas PW; Prange AJ
    Ann N Y Acad Sci; 1982; 400():330-44. PubMed ID: 6132577
    [No Abstract]   [Full Text] [Related]  

  • 2. The manifold actions of neurotensin: a first synthesis.
    Prange AJ; Nemeroff CB
    Ann N Y Acad Sci; 1982; 400():368-75. PubMed ID: 6132578
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurotensin effects on brain dopaminergic systems.
    Haubrich DR; Martin GE; Pflueger AB; Williams M
    Brain Res; 1982 Jan; 231(1):216-21. PubMed ID: 7198926
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroanatomical sites of action of neurotensin.
    Kalivas PW; Nemeroff CB; Prange AJ
    Ann N Y Acad Sci; 1982; 400():307-18. PubMed ID: 6963113
    [No Abstract]   [Full Text] [Related]  

  • 5. Interactions between catecholamines and serotonin: relevance to the pharmacology of schizophrenia.
    Svensson TH; Mathé JM; Nomikos GG; Schilström B; Marcus M; Fagerquist M
    Adv Pharmacol; 1998; 42():814-8. PubMed ID: 9328022
    [No Abstract]   [Full Text] [Related]  

  • 6. Gamma-type endorphins and brain dopaminergic systems.
    van Ree JM; Elands J; Kiraly I; Wolterink G
    Prog Clin Biol Res; 1990; 328():287-90. PubMed ID: 1968266
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing.
    Kalivas PW; Nemeroff CB; Prange AJ
    Neuroscience; 1984 Apr; 11(4):919-30. PubMed ID: 6738859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens.
    Kalivas PW; Richardson-Carlson R; Duffy P
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1126-31. PubMed ID: 3755755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonization of the behavioral activation produced by direct stimulation of forebrain dopamine receptors caused by intraaccumbens injections of neurotensin.
    Ervin GN; Nemeroff CB
    Neuropsychopharmacology; 1988 Sep; 1(3):243-50. PubMed ID: 3150806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity.
    Arnt J; Christensen AV; Hyttel J; Larsen JJ; Svendsen O
    Eur J Pharmacol; 1982 Dec; 86(2):185-98. PubMed ID: 6130958
    [No Abstract]   [Full Text] [Related]  

  • 11. Electrophysiological correlates of psychomotor stimulant-induced sensitization.
    Henry DJ; White FJ
    Ann N Y Acad Sci; 1992 Jun; 654():88-100. PubMed ID: 1385937
    [No Abstract]   [Full Text] [Related]  

  • 12. Behavioral and neurochemical effect of daily injection with neurotensin into the ventral tegmental area.
    Kalivas PW; Taylor S
    Brain Res; 1985 Dec; 358(1-2):70-6. PubMed ID: 4075132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine-dependent contralateral circling induced by neurotensin applied unilaterally to the ventral tegmental area in rats.
    Holmes LJ; Wise RA
    Brain Res Bull; 1985 Nov; 15(5):537-8. PubMed ID: 4063843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unique effect of remoxipride on dopamine utilization in the basal ganglia.
    Fuxe K; Ogren SO
    Acta Physiol Scand; 1991 Apr; 141(4):577-8. PubMed ID: 1678908
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
    Ford AP; Marsden CA
    Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin: perchance an endogenous neuroleptic?
    Nemeroff CB
    Biol Psychiatry; 1980 Apr; 15(2):283-302. PubMed ID: 6106513
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurotensin, N-acetyl-aspartylglutamate and beta-endorphin modulate [3H]dopamine release from guinea pig nucleus accumbens, prefrontal cortex and caudate-putamen.
    Weatherspoon JK; Frank AR; Werling LL
    Neuropeptides; 1996 Oct; 30(5):497-505. PubMed ID: 8923514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of microinjection of 2-chloro-11 (2-dimethylaminoethoxy)-dibenzo[b,f]-thiepine (zotepine), thioridazine and haloperidol into the striatum and nucleus accumbens on stereotypic behaviour and motor activity.
    Lai H; Carino MA; Sperry R; Horita A
    J Pharm Pharmacol; 1981 Apr; 33(4):252-4. PubMed ID: 6115914
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurotensin blocks certain amphetamine-induced behaviours.
    Ervin GN; Birkemo LS; Nemeroff CB; Prange AJ
    Nature; 1981 May; 291(5810):73-6. PubMed ID: 7231526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens.
    Laitinen K; Crawley JN; Mefford IN; De Witte P
    Brain Res; 1990 Jul; 523(2):342-6. PubMed ID: 1698106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.